Abiopharma

New Form 425 - Monogram Technologies Inc. Filed: 2025-09-05 AccNo: 0001104659-25-087632 Size: 31 KB

New Form 8-K - Monogram Technologies Inc. Filed: 2025-09-05 AccNo: 0001104659-25-087631 Size: 208 KB Item 8.01: Other Events

New Curaleaf Branded Dispensary Opens in New Albany, Ohio, in Partnership with RC Retail 2

New Form S-3ASR - Viridian Therapeutics, Inc.\DE Filed: 2025-09-05 AccNo: 0001193125-25-196564 Size: 771 KB

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Theratechnologies Announces Availability of EGRIFTAWR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy

iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

New Form 6-K - IM Cannabis Corp. Filed: 2025-09-05 AccNo: 0001178913-25-003251 Size: 21 KB

New Form 6-K - GSK plc Filed: 2025-09-05 AccNo: 0001654954-25-010429 Size: 2 MB

New Form 6-K - RedHill Biopharma Ltd. Filed: 2025-09-05 AccNo: 0001558370-25-011883 Size: 2 MB

REGENXBIO Presents Positive Twelve-Month Pivotal Data from Phase I/II/III CAMPSIITE® Trial of RGX-121 for Treatment of MPS II

REGENXBIO Presents Positive Twelve-Month Pivotal Data from Phase I/II/III CAMPSIITE® Trial of RGX-121 for Treatment of MPS II

uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

New Form POS AM - GeneDx Holdings Corp. Filed: 2025-09-05 AccNo: 0001818331-25-000117 Size: 59 KB

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)